Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers

NCT02931214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GMI-1359
DRUG: Placebo

Sponsor

GlycoMimetics Incorporated

Collaborators

[object Object]